No products in the cart.
Phase II trial reports leukemia remissions using engineered T cell therapy
1. 90% of relapsed B-cell acute lymphoblastic leukemia (ALL) patients achieved complete remission 1 month after an infusion of engineered ...
Tag: acute lymphoblastic leukemia
![Combo angiotensin-neprilysin inhibitor superior to enalapril in heart failure [PARADIGM-HF trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/Angiotensin-350x250.jpg)
2 Minute Medicine Rewind September 8 – September 14, 2014
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Angiotensin–Neprilysin ...
Severe subtype of acute lymphoblastic leukemia susceptible to FDA-approved kinase inhibitors
1. The prevalence of Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL) increased with age and was associated with worse overall ...
Delaying intrathecal therapy in leukemia may preclude need for cranial radiotherapy
Image: PD 1. Delaying the first round of triple intrathecal therapy (TIT) until peripheral blasts were cleared improved CNS ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.